Emergence of parapneumonic empyema in the USA

Thorax

Volumn 66, Issue 8, 2011, Pages 663-668

  Grijalva, Carlos G ^a   Zhu, Yuwei ^a   Pekka Nuorti, J ^b   Griffin, Marie R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EMPYEMA; FATALITY; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PARAPNEUMONIC EMPYEMA; PNEUMOCOCCAL EMPYEMA; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 79960597529     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.156406     Document Type: Article

References (36)

1. Septimus E. Pleural effusion and empyema. In: Mandell GL, Bennett JE RD, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Edinburgh: Churchill Livingstone, 2009:917-24.
2. Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality. Chest 1991;99:1162-5.
3. Ahmed RA, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. Am J Med 2006;119:877-83. (Pubitemid 44415617)
4. Finley C, Clifton J, Fitzgerald JM, et al. Empyema: an increasing concern in Canada. Can Respir J 2008;15:85-9. (Pubitemid 351676396)
5. Li ST, Gates RL. Primary operative management for pediatric empyema: decreases in hospital length of stay and charges in a national sample. Arch Pediatr Adolesc Med 2008;162:44-8.
6. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2004;113:1735-40. (Pubitemid 38697984)
7. Ruoff KL. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin Microbiol Rev 1988;1:102-8.
8. Maskell NA, Davies CW, Nunn AJ, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-74. (Pubitemid 40300295)
9. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002;34:434-40. (Pubitemid 34112262)
10. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West: emergence of nonvaccine serogroups. Clin Infect Dis 2005;41:21-9. (Pubitemid 40863739)
11. Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006;25:250-4. (Pubitemid 43379067)
12. Obando I, Munoz-Almagro C, Arroyo LA, et al. Pediatric parapneumonic empyema, Spain. Emerg Infect Dis 2008;14:1390-7.
13. Roxburgh CS, Youngson GG, Townend JA, et al. Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child 2008;93:316-18. (Pubitemid 352025830)
14. Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 2010;125:26-33.
15. Grijalva CG, Nuorti JP, Zhu Y, et al. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 2010;50:805-13.
16. Lee GE, Lorch SA, Sheffler-Collins S, et al. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics 2010;126:204-13.
17. Agency for Healthcare Research and Quality. The Healthcare Cost and Utilization Project. Overview of the Nationwide Inpatient Sample. http://www.hcupus.ahrq.gov/nisoverview.jsp (accessed 10 Aug 2010).
18. Agency for Healthcare Research and Quality. The Healthcare Cost and Utilization Project. Hospital Inpatient Statistics, 1996. http://www.hcup-us. ahrq.gov/reports/natstats/his96/clinclas.htm (accessed 10 Aug 2010).
19. Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007;369:1179-86. (Pubitemid 46527876)
20. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 2003;22:499-504.
21. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32-41.
22. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006;295:1668-74.
23. Tsai CJ, Griffin MR, Nuorti JP, et al. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008;46:1664-72. (Pubitemid 351706762)
24. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46. (Pubitemid 36514704)
25. Tan TQ, Mason EO Jr, Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 2002;110:1-6. (Pubitemid 34742634)
26. Ampofo K, Herbener A, Blaschke AJ, et al. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J 2010;29:905-9.
27. Byington CL, Hulten KG, Ampofo K, et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010;48:520-5.
28. Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006;174:817-23. (Pubitemid 44511664)
29. Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155-64. (Pubitemid 351269151)
30. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455-63.
31. Anthonisen NR. Empyema. Can Respir J 2008;15:69-70.
32. Avansino JR, Goldman B, Sawin RS, et al. Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis. Pediatrics 2005;115:1652-9. (Pubitemid 43843176)
33. Eltringham G, Kearns A, Freeman R, et al. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol 2003;41:521-2. (Pubitemid 36098641)
34. Tarrago D, Fenoll A, Sanchez-Tatay D, et al. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect 2008;14:828-34.
35. Ploton C, Freydiere AM, Benito Y, et al. Streptococcus pneumoniae thoracic empyema in children: rapid diagnosis by using the Binax NOW immunochromatographic membrane test in pleural fluids. Pathol Biol (Paris) 2006;54:498-501. (Pubitemid 44794357)
36. Le Monnier A, Carbonnelle E, Zahar JR, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis 2006;42:1135-40.